J&J: 'We can’t stop Pfizer launching Remicade biosimilar in the US'
J&J cannot stop Inflectra arriving in the US in October but warns Pfizer of the risk of launching it while the patent surrounding Remicade’s manufacture remains unresolved.
Archives for September 13, 2016
Customisable chromatography resin maker Avitide boosted by Series D funding
Custom-made affinity resins can offer biomanufacturers flexibility and shorten development timelines says Avitide, fresh from securing Series D financing from Mithril Capital Management.
Lonza licenses rights to sell synthetic AAVs to gene therapy developers
Lonza has licensed rights to synthetic adeno-associated viral (AAV) vectors developed by scientists at US hearing research centre, Massachusetts Eye and Ear.
Jacobs joins GE Healthcare as developer of Pfizer's China mAb plant
Jacobs Engineering Group has been contracted to collaborate with GE Healthcare on the development of Pfizer’s $350m monoclonal antibody manufacturing centre in Hangzhou, China.